Cancer research at a global scale: Key findings from the new Nature Index supplement

 

Nature Indext_Cancer_imageThe latest Nature Index supplement, on cancer research, was launched in April, taking a look at the global challenge of tackling a disease whose incidence is on the rise. Countries are meeting the challenge in different ways, such as through nationwide action plans and broadening early-detection programs. However, coordinating these efforts to make them accessible, targeted and effective is a balancing act.

The supplement explores the factors that are shaping these first lines of defense and the research efforts that are informing them, and includes editorial articles on

It also includes “branded content” articles, created for partner organizations by our Nature Custom Media team.

There are also rankings of the top institutions and countries/territories for cancer research in the Nature Index and an analysis of the locations specializing in particular areas of the field, as well as almost a dozen articles from partners.

 Interested in showcasing your organization’s cancer research? Get in touch to learn more about our sponsorship opportunities.


Nature Indext_Cancer_coverAbout Nature Index supplements:

Nature Index supplements are special features published in Nature using data from the Nature Index database. Organizations are invited to feature in partner articles in the supplements to communicate their prominence on a particular topic.

This year’s topics include:
China, Cancer, Chemistry, Nanoscience and Nanotechnology, Regenerative Medicine, Biomedical Engineering and Europe.
Discover upcoming topics and how to get involved >>

 


Nature Conference_Next Generation Cancer Therapeutics_Oct26Upcoming Nature Conference

Explore the conversation further around the same topic: This October, the Next Generation Cancer Therapeutics conference brings together researchers from academia, biotech, and pharma to discuss emerging strategies shaping the future of cancer treatment.

Taking place 6–8 October 2026 in Houston, Texas, the in‑person event will spotlight next‑generation therapeutics, innovative platforms, and the role of AI in drug development.

Register to attend or explore sponsorship opportunities.

See all posts